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Objective: To invest the differences among mesenchymal stem cells (MSCs) derived
from different tissues and their impacts on clinical applications.
Methods: In this study, MSCs were isolated from adipose tissue (AD), umbilical cord
tissue (UC), and menstrual blood (Men) and compared their biological characteristics in
terms of proliferation capacity, passage capacity, colony formation, and surface markers
were compared.
Results: The stem cells (SCs) obtained from different sources were all characterized as
MSCs, but demonstrated some differences. Umbilical cord-derived MSCs (UCMSCs)
were able to overcome density inhibition. The proliferation rate decreased in the order
UCMSCs > MenSCs > ADSCs, while the colony-forming ability decreased in the order
MenSCs > ADSCs > UCMSCs. Based on gene-expression data for MSCs from different
sources within the same donor, 768 MenSC genes were found that were speciﬁcally
upregulated or downregulated compared with bone marrow-derived MSCs and UCMSCs,
most of which were involved in cell function-related pathways. In addition, MenSCs
appeared to be superior in terms of immune inﬂammation, stress response, and neural
differentiation potentials, but weaker in terms of osteogenic and chondrogenic differen-
tiation capacities, compared with UCMSCs and bone marrow-derived MSCs.
Conclusions: MenSCs have higher extraction efﬁciency, colony-forming ability, and
long time passage capacity. Although the proliferation capacity is inferior to UCMSCs.1. Introduction
Mesenchymal stem cells (MSCs) are a class of adult stem
cells with characteristics of self-renewal and pluripotency.
MSCs can not only differentiate into mesenchymal cell lineages,
but also into non-mesenchymal cell lineages, including astro-
cytes, oligodendrocytes, and neurons. Studies on thepluripotency of MSCs have laid a solid foundation for their
clinical application in the ﬁeld of regenerative medicine [1–3].
Current research on MSCs is mainly focused on their self-
renewal capacity, multi-lineage differentiation potential, surface
markers, and immune regulation. Several studies have shown that
MSCs derived from different tissues demonstrate a certain extent
differences in terms of some of the above-mentioned aspects.
Although the immunophenotypes of MSCs comply with the
minimum standards of the International Society for Cellular
Therapy, there is no agreement on the expression of other mo-
lecular markers. For example, amniotic ﬂuid-derived MSCs sus-
tainably expressed embryonic stem cell-speciﬁc markers such as
Nanog, SSEA-4 and OCT-4. OCT-4 expression levels were 9.4
times higher than in bonemarrow-derivedMSCs (BMSCs), while
SSEA-4 expression was low in BMSCs but high in amniotic ﬂuid-
derived MSCs [4]. Menstrual blood-derived stem cells (MenSCs)
are novel stem cells with the basic characteristics of MSCs, butopen access article under the CC BY-NC-ND
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MenSCs expressed OCT-4, but not NANOG or SSEA-4 [5–7],
while Rossignoli et al. [8] reported that 19.4% of MenSCs were
SSEA-4-positive by ﬂow cytometry. Zemel'ko et al. [9] showed
high expression of SSEA-4 by immunoﬂuorescence.
MSCs from different tissues also display signiﬁcant differ-
ences in proliferative potential. Barlow et al. [10] suggested that
the proliferation rate of adipose-derived mesenchymal stem cells
(ADSCs) was much higher than that of BMSCs or placenta-
derived MSCs. However, placenta-derived MSCs were able to
maintain a longer proliferative phase and be continuously
cultured for up to 160 d, with up to 64 population doublings. In
contrast, BMSCs can only be continuously cultured for 60 d,
with up to 12 population doublings [10]. Another study reported
that the population-doubling time in umbilical cord-derived
mesenchymal stem cells (UCMSCs) was much lower than that
of ADSCs, but UCMSCs showed earlier morphological changes
and a more rapid decline in ampliﬁcation ability [9–11]. Some
studies found that amniotic ﬂuid-derived MSCs and ADSCs
exhibited different levels of telomerase activity [12], suggesting
different ampliﬁcation characteristics.
Studies on the differentiation potentials of MSCs from various
sources have conﬁrmed the differentiation potential of mesoderm
three-line, but their capacity to differentiate into cells of other
lineages remains controversial. Panepucci et al. [13] suggested that
the functional difference between MSCs from different sources
may be related to the origin of the cells. BMSCs are prone to
differentiate into osteoblasts, while UCMSCs are prone to
angiogenesis, conﬁrming the ‘imprint’ differentiation potential
theory of MSC lineage proposed by Satomura et al. [14].
However, Liu et al. [15] believed that the strong potential of
BMSCs to differentiate into osteoblasts was due to the presence
of more osteogenic and chondrogenic progenitor cells in BMSC
cultures, rather than in the inherent characteristics of BMSCs.
Numerous studies have investigated the differentiation potential
of MSCs. Some researchers reported that sex differences affected
the osteoblast-cytogenesis efﬁciency of MSCs, with ADSCs
frommale donors beingmore likely to differentiate than those from
female donors [16]. Researchers also found that the osteogenic, but
not adipogenic potential of ADSCs declined with age [17].
Low immunogenicity and immune regulation are important
features of MSCs, making them suitable for allotransplantation.
Melief et al. showed that, although both BMSCs and ADSCs
had immunomodulatory functions, differences in cytokine
secretion led to ADSCs having a stronger immunomodulatory
function, equal to that of BMSCs [18]. Another similar study
suggested that the immunomodulatory ability of placenta-
derived MSCs was superior to that of BMSCs and ADSCs [19].
Biological differences among MSCs derived from different
tissues determine their different clinical applications. In the
current study, we isolated MSCs from adipose tissues, umbilical
cord tissues and menstrual blood using different separation
methods, and compared their biological characteristics, genetic
stabilities, and gene expression patterns, to provide reference
information to aid future clinical cell therapies.
2. Materials and methods
2.1. Sample sources
Adipose tissues (n = 6), umbilical cord tissues (n = 6), bone
marrow samples (n = 1) and menstrual blood samples (n = 6)were obtained from 17 healthy donors recruited from the First
Afﬁliated Hospital of Zhejiang University, Hangzhou, China.
The donors were informed about the preparation and application
of the specimens before collection, and signed informed consent
was obtained. The study was approved by the ethical committee
of the First Afﬁliated Hospital of Zhejiang University.
2.2. Cell isolation and culture
2.2.1. ADSC isolation and culture
Liposuction was performed in healthy donors to aspirate
lipid, as described by Zuk et al. [20]. The lipid was cut into
pieces, digested with 0.1% type I collagenase (Roche,
Penzberg, Germany) at 37 C for 30 min, neutralized with
medium, and washed. The cells were then resuspended in
DMEM containing 10% fetal bovine serum (Hyclone, Logan,
UT), seeded into a culture ﬂask, and placed in a 5% CO2
incubator with saturated humidity at 37 C. When the cells
reached 80%–90% conﬂuence, they were digested with 0.25%
trypsin-EDTA (Gibco, Carlsbad, CA), seeded in a ﬂask at a
density of 5 × 103/cm2, and successively passaged until cell
senescence (cells were unable to be ampliﬁed).
2.2.2. UCMSC isolation and culture
Umbilical cord tissue (5–10 cm) was stripped from healthy
women during labor, treated with Watertown's glue, and cut into
pieces about 1 mm3. DMEM medium (Hyclone) containing 10%
fetal bovine serum was added and the cells were seeded into a
culture ﬂask, and placed in a 5% CO2 incubator with saturated
humidity at 37 C for primary adherent culturing. Passaging was
carried out as above.
2.2.3. MenSC isolation and culture
Menstrual blood was collected from healthy women on the
second day of menstruation using a menstruation cup (E-vans
Biotech, Hangzhou, China), mixed thoroughly, and ﬁltered
through 150–mm mesh. Mononuclear cells were isolated by
density-gradient centrifugation. Menstrual stem cell culture
medium (E-vans Biotech) was then added, the cells were seeded
in a culture ﬂask and cultured in a 5% CO2 incubator with
saturated humidity at 37 C. Cells were passaged as described
above.
2.2.4. BMSC isolation and culture
Human bone marrow was collected from healthy adult do-
nors. BMSCs were harvested according to the methods
described by Barlow et al. [10]. Mononuclear cells were isolated
and plated in culture ﬂasks.
2.3. Analysis of cell proliferation characteristics
2.3.1. Growth curve
The three kinds of cells of the same generation (P5) were
selected by MTT assay to determine the growth curve. The cells
were seeded in 96-well culture plates at a density of 1000 cells per
well. The cells were measured every 24 h, at six parallel points.
Another group served as a blank control. The culture was main-
tained for 7 d, after which 20 mL ofMTT solution (Sigma–Aldrich,
St. Louis,MO)was added into each testwell. The cellswere further
cultured in an incubator at 37 C for 4 h, and the cultures were then
terminated. The supernatant was carefully aspirated and discarded
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each well, followed by shaking for 10 min. The optical density of
eachwell wasmeasured at 490 nm. The resultswere recorded and a
cell growth curve was constructed.
2.3.2. Population doublings
Detailed data on cell passaging were recorded as described in
Section 2.2, and the population doublings for each group of cells
were calculated [21].
2.3.3. Determination of cell-colony formation
Cell cloning experiments were performed with P5 cells in
logarithmic growth phase [21]. One hundred, 200, or 300 cells
were added to each well of a six-well plate in a density
gradient, and 3 mL of culture medium was added per well. The
plates were placed in a 5% CO2 incubator with saturated hu-
midity at 37 C for 2–3 wk, with the medium replaced every 3 d.
The cultures were terminated when the clones became visible in
the culture plates. The supernatant was discarded and the cells
were rinsed twice with phosphate-buffered saline and ﬁxed with
5 mL methanol for 15 min. The ﬁxation ﬂuid was discarded and
Giemsa staining solution was added for 10–30 min. The staining
solution was slowly washed off with water and the cells were air
dried. Clones with more than 10 cells were counted under a
microscope, and the colony-forming rate was calculated.
2.4. Flow cytometric analysis
P5 cells at 80%–90% conﬂuence were collected, washed and
used to prepare a 1.0 × 105/mL cell suspension. Mouse anti-
human monoclonal antibodies against CD29, CD34, CD45,
CD73, CD90, CD105, and HLA-DR, CD117, SSEA-4 were
added, respectively, at 20 mL each. The solution was mixed and
incubated at 4 C or on ice for 30 min away from light. The
solution was then centrifuged and the supernatant was discarded.
Phosphate-buffered saline BS was added to the cell pellet,
centrifuged, and washed twice. Cells were then detected using a
ﬂow cytometer (FC500MCL, Beckman Coulter, Fullerton, CA)
after resuspension.Figure 1. Morphological observations of MSCs from umbilical cord (UCSCs)
tenth (P10), and twentieth (P20) passages. Scale bar, 100 mm.2.5. Gene expression analysis
Affymetrix gene chips (Human U133 Genome Array) were
used for mRNA expression proﬁling. Experimental protocols
for the gene chips were performed according to the manufac-
turer's technical instructions. RNA was isolated from 1.0 × 106
P5 cells using Trizol reagent (Invitrogen, Grand Island, NY).
Total RNA was puriﬁed using a Qiagen RNeasy mini kit
(Qiagen, Valencia, CA). Single and double-stranded cDNAs
were synthesized from total RNA samples using SuperScript II
(Invitrogen, CA). Biotin-labeled cRNA was also synthesized.
Microarray hybridization was performed, after which the chips
were washed, scanned, and image acquisition was carried out.
GCOS 1.4 was used to analyze the image data. After RNA
normalization, differences in expression levels between two
conditions were analyzed by Student's t-tests. A P value < 0.01
and fold change >2 were considered to indicate a signiﬁcant
difference. An intersection of differential expression for
MenSC4 compared with UCMSC4, and for MenSC5 compared
with BMSC5 was used to identify genes differentially
expressed in MenSCs. Differentially-expressed genes were
analyzed using the Database for Annotation, Visualization and
Integrated Discovery (DAVID, available at http://david.abcc.
ncifcrf.gov/).
2.6. Statistical analysis
The data were analyzed by one-way analysis of variance
using SPSS 16.0 software. The data were expressed as
mean ± standard deviation. P < 0.05 was considered signiﬁcant.
3. Results
3.1. Morphological observations of MSCs derived from
different tissues
We isolated MSCs from human adipose tissues, umbilical
cord tissues and menstrual blood, with a success rate of 100%.
During primary culture, most spindle cells were arranged, adipose tissue (ADSCs), and menstrual blood (MenSCs) at the ﬁfth (P5),
Figure 2. Comparison of proliferation characteristics of MSCs from umbilical cord (UCSCs), adipose tissue (ADSCs), and menstrual blood (MenSCs).
(A) Population doubling (n = 6); (B) growth curves; and (C) colony-forming abilities (n = 6) of UCSCs, ADSCs, and MenSCs.
Table 1
Immunophenotypic analysis of ADSCs, UMSCs and MenSCs at passage
5.
Molecular
marker
ADSCs
(%) (n = 6)
MenSCs
(%) (n = 6)
UCMSCs
(%) (n = 6)
CD29 90.14 ± 0.20 90.20 ± 0.30 91.25 ± 0.20
CD34 0.36 ± 0.20 0.26 ± 0.30 0.56 ± 0.20
CD45 0.78 ± 0.40 11.22 ± 3.00 0.80 ± 0.50
CD73 95.90 ± 1.80 95.36 ± 1.10 96.86 ± 0.40
CD90 99.64 ± 0.30 94.98 ± 1.70 99.90 ± 0.30
CD105 90.72 ± 5.60 79.64 ± 4.30 94.56 ± 2.10
CD117 10.84 ± 1.30 10.20 ± 1.60 7.56 ± 1.30
HLA-DR 0.66 ± 0.40 0.66 ± 0.30 0.44 ± 0.20
SSEA-4 0.26 ± 0.20 0.48 ± 0.30 0.80 ± 0.40
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cells were observed besides the long spindle cells in primary
adherent blood cell cultures. Cells gradually formed single,
spindle communities with increasing passage numbers. Cells
derived from umbilical cord and menstrual blood could reach
80% conﬂuence after 2–3 wk, while the growth rate of primary
adipocytes was slower, i.e. 3–4 wk.
As shown in Figure 1, MenSCs had the largest single-cell
volume and UCMSCs the smallest. Cell–cell contact inhibition
was remarkable in ADSCs and MenSCs, but insigniﬁcant in
UCMSCs, with overlap of cells. The volume of the MSCs
increased gradually with increasing passage number and the
cells became ﬂattened, making it difﬁcult for them to form a
single monolayer. UCMSCs and ADSCs gradually differentiated
into polygonal cells with long protrusions, while severe granu-
lation appeared on the surface of MenSCs.
3.2. Cell proliferation
According to the growth curve of P5MSCs, UCMSCs showed
the strongest proliferative capacity, with a doubling time of about
21 h, compared with doubling times for MenSCs and ADSCs of
approximately 26 and 30 h, respectively (Figure 2B). UCMSCs
had the fastest proliferation rate, followed by MenSCs, while thedoubling rate of ADSCs remained similar throughout the pas-
sages. MenSCs initially proliferated slowly, reached a peak at P8,
and then gradually decreased, allowing them to maintain a high
proliferative activity. UCMSCs sustained rapid multiplication
until P16, and then followed the same trend as ADSCs and
MenSCs. Population doublings reduced with increasing passage
(Figure 2A). The clonality of the different MSC types declined in
the order MenSCs > ADSCs > UCMSCs (Figure 2C).
Figure 3. Karyotypes of ADSCs, UCMSCs and MenSCs at passages 10 and 20.
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Stromal cell markers (CD29, CD73, CD90, CD105) were
expressed in ADSCs, MenSCs and UCMSCs, with a high
positivity rate. However, hematopoietic cell markers (such as
CD34 and CD45), the human embryo developmental stage-
speciﬁc phenotype SSEA-4, and the immune marker HLA-Figure 4. Dendrogram of differential gene expression.
Each color box represents the signal values of a probe on the chip (green = low
MenSC4 VS UCMSC4 indicates differential expression of genes between Men
UCMSC4 (invalid signal) but were highly expressed in MenSC4 (valid signal)
kinds of cells, with a >2-fold change (P < 0.01) comprise list 1. Genes that w
MenSC5 (valid signal) with >10-fold change, and genes that were effectively e
list 2. UCMSC4 and MenSC4 were isolated from the same donor, and BMSCDR were not expressed, suggesting low immunogenicity
(Table 1).
3.4. Detection of cell stability
Karyotype analysis was performed in MSCs at P10 and P20
to verify the genetic stability of the cells after cell passage. Thesignal, red = high signal). The brightness reﬂects the intensity of the signal.
SCs and UCMSCs from the same donor. Genes that were not expressed in
with a >10-fold change, and genes that were effectively expressed in both
ere not expressed in BMSC5 (invalid signal) but were highly expressed in
xpressed in both kinds of cells, with a >2-fold change (P < 0.01) comprise
5 and MenSC5 were isolated from the same donor.
Table 2
Pathways signiﬁcantly enriched for differentially-expressed genes.
Pathway Count P value Gene
Systemic lupus erythematosus 23 5.76E-22 Up:
C4B;C4A;HIST1H2BC;HIST1H2BE;HIST1H2BF;HIST1H2BG;HIST1H
2BI;HIST3H2A
Down:
H2AFX;HIST1H4A;HIST1H4B;HIST1H4C;HIST1H4D;HIST1H4E;HIS
T1H4F;HIST1H4H;HIST1H4I;HIST1H4J;HIST1H4K;HIST1H4L;HIST2
H4B;HIST2H4A;HIST4H4
MAPK signaling pathway 16 6.21E-09 Up:
ACNA2D3;RASGRP2;ARRB1;DUSP5;ARRB1;HSPA2;HSPA1A;
HSPA1B;DUSP4;DUSP1;GADD45B;MAP3K5;MAPK13;MKNK2
Down:
RPS6KA2;BDNF;RPS6KA2;BDNF;TGFBR1
O-Glycan biosynthesis 7 1.06E-08 Up:
Down:
GALNT1;GALNT10;GALNT13;GCNT1;GALNT3;GALNT5;C1GALT1
TGF-b signaling pathway 9 1.06E-07 Up:
BMP2
Down:
DCN;DCN;DCN;ID4;LTBP1;DCN;ID3;LTBP1;CDKN2B;ACVR2A;
TGFBR1;INHBA
Complement and coagulation
cascades
8 2.23E-07 Up:
MASP1;PLAU;PLAU;F3;PROS1;C4B;C4A;BDKRB2
Down:
CFH
p53 signaling pathway 8 2.23E-07 Up:
GTSE1;GADD45B;RRM2;CCNB1;CCNB2
Down:
ATM;LOC651610;IGFBP3
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serial passages of MSCs from all three origins (Figure 3).
3.5. Gene expression analysis
Samples of menstrual blood and umbilical cord, and samples
of menstrual blood and bone marrow were collected from the
same donor. Differences in gene expression caused by different
genetic backgrounds were investigated by comparing the
genome-wide expression spectra of the samples using an Affy-
metrix microarray. A total of 768 genes speciﬁcally upregulated
or downregulated in MenSCs were found (Figure 4A). The
upregulated genes included CD44, MAP3K5, IFITM1, and
NES, and the downregulated genes included POSTN, OSTM1,
and IGFBP3. The main pathways showing signiﬁcant enrich-
ment of differentially-expressed genes were the transforming
growth factor (TGF)-b, mitogen-activated protein kinase
(MAPK), p53, type II diabetes, cytokines and their receptors,
insulin signaling and other cell function-related pathways. The
main pathways enriched for downregulated genes were the
systemic lupus erythematosus, O-glycan biosynthesis, and TGF-
b signaling pathways. The MAPK signaling pathway, comple-
ment and coagulation cascade pathway, and type II diabetes
pathway showed more enrichment of upregulated genes
(Table 2).
4. Discussion
BMSCs are widely-used adult stem cells that provide an ideal
resource for cell therapy. However, there remain many unre-
solved issues regarding the clinical application of BMSCs,
including the fact that cell numbers and their multi-directionaldifferentiation potential are inﬂuenced by age [22]. Researchers
are therefore investigating suitable alternative cell sources.
Umbilical cord-derived UCMSCs and menstrual blood-derived
MenSCs have attracted much attention. This study aimed to
demonstrate the differences between ADSCs, UCMSCs and
MenSCs with respect to their in vitro and molecular
characteristics.
MSCs derived from all three sources produced long, spindle
cells in vitro culture. However, differences among the three cell
types became evident during cell culture. 1) There were obvious
differences in cell–cell contact inhibition; ADSCs and MenSCs
were signiﬁcantly inhibited, while UCMSCs were not. 2)
MenSCs had the largest cell volume, and UCMSCs the smallest.
3) Different numbers of MSCs were obtained from different
sources [23]. In this study, although MSCs could be isolated
successfully from the three different tissues, the resulting cells
showed noticeable differences in cultivation rates. Compared
with ADSCs and UCMSCs, MenSCs had a higher isolation
rate. Previous studies showed that ADSCs accounted for 2%
of karyocytes [24], while UCMSCs accounted for 0.08% [25].
MSCs from different tissues demonstrated different capabil-
ities in terms of cell proliferation and passage. Growth curve
analysis and passage experiments indicated that UCMSCs had
the strongest ampliﬁcation potential, followed by MenSCs and
ADSCs. In contrast, MenSCs showed signiﬁcantly higher pas-
sage ability than UCMSCs and ADSCs.
Our study showed that all three kinds of MSCs had colony-
forming abilities, consistent with previous reports [26]. MenSCs
had greater clonality than ADSCs and UCMSCs. Regarding the
colony-forming ability of MenSCs, it was reported that single-
cell suspensions derived from uterine tissue formed two types
of colonies after 15 d, including endometrial epithelial cells
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[27].
Karyotype analysis is used to analyze the morphological
characteristics of the chromosomes in the nucleus, which forms
the fundamental basis for species classiﬁcation. Previous studies
reported a lower probability of chromosomal variations in long-
term MSC cultures [28–30]. In this study, we found no
chromosomal abnormalities in any of the three kinds of MSCs
at P10 or P20, suggesting chromosomal stability at least until
P20.
Regarding immunophenotyping, we analyzed the expression
of CD29, CD34, CD45, CD73, CD90, CD105, CD117, SSEA-4
and HLA-DR by ﬂow cytometry and found no signiﬁcant dif-
ferences among the three kinds of MSCs. All three kinds of
MSCs were negative for the hematopoietic stem cells markers
CD34 and CD45, but positive for the typical MSC markers
CD29, CD73, CD90 and CD105. SSEA-4 is an early embryonic
carbohydrate antigen usually used to label human micro differ-
ential pluripotent embryonic stem cells and embryo decompo-
sition products at the blastocyst stage. Our cells were negative
for SSEA-4, consistent with previous reports [31–34]. HLA-DR
was also negative, which conﬁrmed the immunogenicity of
MSCs.
Gene expression is regulated by a variety of factors, and
minimizing these inﬂuences presents a challenge for analyzing
gene expression in MSCs. We therefore compared gene
expression between MenSCs and UCMSCs from the same
donor, and between MenSCs and BMSCs from the same donor.
We then screened 768 genes in MenSCs which were speciﬁcally
upregulated or downregulated under the same genetic
background.
CD44 is an important adhesion molecule that supports and
promotes the migration of MSCs [34]. CD44 expression was 10-
fold higher in MenSCs compared with UCMSCs and BMSCs,
suggesting that MenSCs had stronger adhesion ability in culture.
The insulin-like growth factor-binding protein IGFBP5 can
inhibit binding of insulin-like growth factor (IGF)-1 to its re-
ceptor, further affecting metabolic activities related to cell
growth and survival. IGFBP5 has been shown to inhibit osteo-
blast differentiation [33], and we therefore concluded that
BMSCs had lower IGFBP5 activity than MenSCs, leading to
strong osteogenic or chondrogenic differentiation potential.
POSTN and OSTM1 are important osteogenic and
chondrogenic genes that were largely downregulated in
MenSCs compared with UCMSCs and BMSCs, which also
conﬁrmed the inferior osteogenic and chondrogenic
differentiation potentials of MenSCs.
IGFBP3 can inhibit proliferation and promote apoptosis [32].
IGFBP3 tended to be downregulated in MenSCs, indicating that
these cells were less prone to senescence and apoptosis. This
supported our conclusion that MenSCs had a stronger passage
ability, consistent with the results of in vitro proliferation of
MenSCs in previous studies [31].
MAP3K5 is mainly involved in signal transduction of cell
apoptosis. It also plays an important role in the innate immune
response, and regulates signal transduction of a variety of
stressors and receptor-mediated inﬂammatory signals. As an
interferon-induced transmembrane protein, IFITM1 is associated
with high resistance to various viral infections. High expression
levels of MAP3K5 and IFITM1 implied that MenSCs had
stronger abilities to modulate the inﬂammatory environment and
generate defense reactions.The neuroectodermal marker NES is a key factor in brain
development, and plays an important role in the survival,
renewal and proliferation of neural progenitor cells. Compared
with UCMSCs and BMSCs, NES expression was upregulated
8–14-fold in MenSCs, suggesting a greater differentiation po-
tential in the nervous system.
In summary, the results of this study demonstrated that MSCs
from adipose and umbilical cord tissues and menstrual blood all
displayed the basic characteristics of MSCs, but with signiﬁcant
differences. MenSCs had higher extraction efﬁciency and
stronger colony-forming and long-term passage abilities, but
weaker ampliﬁcation capability compared with UCMSCs. The
coexistence of several cells with different morphologies sug-
gested the existence of more stem cell types in menstrual blood.
Information on gene expression proﬁles of MSCs from different
tissues provides reference information to improve our under-
standing of cell function, and to aid the selection of appropriate
cell types for clinical applications. Analysis of differentially-
expressed genes revealed that MenSCs have advantages in
terms of immune inﬂammation and stress response and neural
differentiation potential, but limited osteogenic and chondro-
genic differentiation abilities, compared with UCMSCs and
BMSCs. This study identiﬁed MenSCs as a prospective source
of cells for the clinical study of regenerative medicine, which
may in turn lay the foundation for screening for speciﬁc mo-
lecular markers of MenSCs.
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